Hält derzeit Positionen bei Novocure Ltd, OptiNose Inc and Minerva Neurosciences Inc
Position | Company | Period |
---|---|---|
Executive Chairman of the Board | Novocure Ltd | 11. Mai 2016 - |
Independent Director | OptiNose Inc | 1. Januar 2010 - |
Lead Independent Director | Minerva Neurosciences Inc | 5. Februar 2018 - |
Director | Minerva Neurosciences Inc | 11. Dezember 2017 - 5. Februar 2018 |
Independent Director | Zoetis Inc | 3. Februar 2015 - 12. Mai 2016 |
Chairman of the Board | Novocure Ltd | 1. Januar 2004 - 11. Mai 2016 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-12 | 2024-03-08 |
Elanco Animal Health Inc
(ELAN)
|
K Kauf |
15.000
+32.4%
16,30244.500 USD |
15.000 +32.4% | 16,30 | 244.500 USD | |
2022-08-03 | 2022-08-02 |
Novocure Ltd
(NVCR)
|
V Verkauf |
837
-0.2%
69,6658.305 USD |
837 -0.2% | 69,66 | 58.305 USD | |
2022-03-09 | 2022-03-08 |
Novocure Ltd
(NVCR)
|
V Verkauf |
2.385
-0.4%
70,10167.189 USD |
2.385 -0.4% | 70,10 | 167.189 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
600
-0.1%
216,69130.016 USD |
600 -0.1% | 216,69 | 130.016 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
500
-0.1%
214,67107.333 USD |
500 -0.1% | 214,67 | 107.333 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.500
-0.3%
213,35320.021 USD |
1.500 -0.3% | 213,35 | 320.021 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
600
-0.1%
211,28126.766 USD |
600 -0.1% | 211,28 | 126.766 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
521
-0.1%
210,18109.504 USD |
521 -0.1% | 210,18 | 109.504 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
2.200
-0.4%
209,34460.555 USD |
2.200 -0.4% | 209,34 | 460.555 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
4.500
-0.8%
207,80935.118 USD |
4.500 -0.8% | 207,80 | 935.118 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.284
-0.2%
206,35264.956 USD |
1.284 -0.2% | 206,35 | 264.956 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.600
-0.3%
205,43328.690 USD |
1.600 -0.3% | 205,43 | 328.690 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.972
-0.3%
204,28402.834 USD |
1.972 -0.3% | 204,28 | 402.834 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
2.555
-0.4%
203,25519.311 USD |
2.555 -0.4% | 203,25 | 519.311 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
4.388
-0.8%
202,16887.069 USD |
4.388 -0.8% | 202,16 | 887.069 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
4.125
-0.7%
201,55831.377 USD |
4.125 -0.7% | 201,55 | 831.377 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
4.338
-0.7%
199,71866.355 USD |
4.338 -0.7% | 199,71 | 866.355 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
10.563
-1.8%
198,982.101.794 USD |
10.563 -1.8% | 198,98 | 2.101.794 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
13.612
-2.2%
197,832.692.876 USD |
13.612 -2.2% | 197,83 | 2.692.876 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
24.338
-3.8%
197,004.794.659 USD |
24.338 -3.8% | 197,00 | 4.794.659 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
8.814
-1.4%
196,071.728.187 USD |
8.814 -1.4% | 196,07 | 1.728.187 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.600
-0.2%
194,94311.904 USD |
1.600 -0.2% | 194,94 | 311.904 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
2.090
-0.3%
193,57404.563 USD |
2.090 -0.3% | 193,57 | 404.563 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.900
-0.3%
192,52365.796 USD |
1.900 -0.3% | 192,52 | 365.796 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
1.400
-0.2%
191,26267.768 USD |
1.400 -0.2% | 191,26 | 267.768 USD | |
2021-04-02 | 2021-04-01 |
Novocure Ltd
(NVCR)
|
V Verkauf |
7.928
-1.2%
134,121.063.303 USD |
7.928 -1.2% | 134,12 | 1.063.303 USD | |
2020-08-03 | 2020-07-31 |
Novocure Ltd
(NVCR)
|
V Verkauf |
896
-0.1%
76,3968.444 USD |
896 -0.1% | 76,39 | 68.444 USD | |
2020-05-12 | 2020-05-11 |
Novocure Ltd
(NVCR)
|
V Verkauf |
31.332
-4.6%
63,731.996.726 USD |
31.332 -4.6% | 63,73 | 1.996.726 USD | |
2020-05-11 | 2020-05-08 |
Novocure Ltd
(NVCR)
|
V Verkauf |
31.903
-4.5%
63,502.025.872 USD |
31.903 -4.5% | 63,50 | 2.025.872 USD | |
2020-05-11 | 2020-05-07 |
Novocure Ltd
(NVCR)
|
V Verkauf |
30.993
-4.5%
64,742.006.518 USD |
30.993 -4.5% | 64,74 | 2.006.518 USD | |
2020-05-07 | 2020-05-06 |
Novocure Ltd
(NVCR)
|
V Verkauf |
29.881
-5.0%
64,271.920.452 USD |
29.881 -5.0% | 64,27 | 1.920.452 USD | |
2020-05-07 | 2020-05-05 |
Novocure Ltd
(NVCR)
|
V Verkauf |
30.283
-4.8%
62,471.891.718 USD |
30.283 -4.8% | 62,47 | 1.891.718 USD | |
2020-03-10 | 2020-03-06 |
Novocure Ltd
(NVCR)
|
V Verkauf |
4.320
-0.8%
69,53300.387 USD |
4.320 -0.8% | 69,53 | 300.387 USD | |
2020-03-02 | 2020-02-28 |
Novocure Ltd
(NVCR)
|
V Verkauf |
3.893
-0.8%
72,22281.133 USD |
3.893 -0.8% | 72,22 | 281.133 USD | |
2020-01-22 | 2020-01-17 |
Novocure Ltd
(NVCR)
|
GV Geplanter Verkauf |
133.777
-20.8%
95,0012.708.815 USD |
133.777 -20.8% | 95,00 | 12.708.815 USD | |
2019-07-01 | 2019-06-27 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
3.500
+15.5%
5,5019.250 USD |
3.500 +15.5% | 5,50 | 19.250 USD | |
2019-06-03 | 2019-05-30 |
Novocure Ltd
(NVCR)
|
V Verkauf |
48.100
-5.4%
53,072.552.523 USD |
48.100 -5.4% | 53,07 | 2.552.523 USD | |
2019-05-31 | 2019-05-29 |
Novocure Ltd
(NVCR)
|
V Verkauf |
1.900
-0.2%
53,10100.881 USD |
1.900 -0.2% | 53,10 | 100.881 USD | |
2019-05-10 | 2019-05-09 |
Novocure Ltd
(NVCR)
|
V Verkauf |
31.460
-3.4%
47,371.490.386 USD |
31.460 -3.4% | 47,37 | 1.490.386 USD | |
2019-05-09 | 2019-05-08 |
Novocure Ltd
(NVCR)
|
V Verkauf |
32.218
-3.6%
47,521.531.032 USD |
32.218 -3.6% | 47,52 | 1.531.032 USD | |
2019-05-09 | 2019-05-07 |
Novocure Ltd
(NVCR)
|
V Verkauf |
32.098
-3.7%
47,671.530.112 USD |
32.098 -3.7% | 47,67 | 1.530.112 USD | |
2019-05-07 | 2019-05-06 |
Novocure Ltd
(NVCR)
|
V Verkauf |
29.038
-3.4%
48,071.395.915 USD |
29.038 -3.4% | 48,07 | 1.395.915 USD | |
2019-05-06 | 2019-05-03 |
Novocure Ltd
(NVCR)
|
V Verkauf |
29.966
-3.7%
45,211.354.643 USD |
29.966 -3.7% | 45,21 | 1.354.643 USD | |
2019-03-01 | 2019-02-28 |
Novocure Ltd
(NVCR)
|
V Verkauf |
3.097
-0.3%
53,68166.247 USD |
3.097 -0.3% | 53,68 | 166.247 USD | |
2018-12-26 | 2018-12-20 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
2.000
+9.7%
6,5013.000 USD |
2.000 +9.7% | 6,50 | 13.000 USD | |
2018-12-12 | 2018-12-11 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
4.000
+24.1%
7,9531.800 USD |
4.000 +24.1% | 7,95 | 31.800 USD | |
2018-12-12 | 2018-12-10 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
2.000
+13.7%
8,0016.000 USD |
2.000 +13.7% | 8,00 | 16.000 USD | |
2018-11-21 | 2018-11-20 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
2.000
+15.9%
8,2016.400 USD |
2.000 +15.9% | 8,20 | 16.400 USD | |
2018-10-15 | 2018-10-11 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
600
+5.0%
10,006.000 USD |
600 +5.0% | 10,00 | 6.000 USD | |
2018-09-19 | 2018-09-17 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
1.800
+17.6%
10,5018.900 USD |
1.800 +17.6% | 10,50 | 18.900 USD | |
2018-09-17 | 2018-09-14 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
200
+2.0%
10,502.100 USD |
200 +2.0% | 10,50 | 2.100 USD | |
2018-09-17 | 2018-09-13 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
2.000
+25.0%
10,5021.000 USD |
2.000 +25.0% | 10,50 | 21.000 USD | |
2018-09-11 | 2018-09-11 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
4.011
+100.3%
9,7238.987 USD |
4.011 +100.3% | 9,72 | 38.987 USD | |
2018-09-11 | 2018-09-10 |
Minerva Neurosciences Inc
(NERV)
|
K Kauf |
4.000
+inf%
9,8839.520 USD |
4.000 +inf% | 9,88 | 39.520 USD |